×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [41]
内容类型
期刊论文 [37]
会议论文 [4]
发表日期
2019 [8]
2018 [4]
2017 [6]
2016 [7]
2015 [6]
2014 [3]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共41条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Hyperglycemia exacerbates acetaminophen-induced acute liver injury by promoting liver-resident macrophage proinflammatory response via AMPK/PI3K/AKT-mediated oxidative stress
期刊论文
2019, 卷号: 5, 页码: 119
作者:
Wang Qi
;
Wei Song
;
Zhou Haoming
;
Shen Gefenqiang
;
Gan Xiaojie
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Acute inflammation
Kupffer cells
DESIGN, SYNTHESIS AND ANTIBACTERIAL EVALUATION OF 1-[(1R,2S)-2-FLUOROCYCLOPROPYL] CIPROFLOXACIN-(4-METHYL-3-ARYL)-1,2,4-TRIAZOLE-5(4H)-THIONE HYBRIDS
期刊论文
2019, 卷号: 64, 期号: 1, 页码: 101-107
作者:
Geng, Yun-He
;
Wei, Zeng-Quan
;
Xu, Zhi
;
Na, Lu-Xin
;
Zhang, Shu
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
quinolone
ciprofloxacin
1
2
4-triazole-5(4H)-thione
hybrids
antibacterial
structure-activity relationship
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women
期刊论文
2019
作者:
Wong Jason Y Y
;
Zhang Han
;
Hsiung Chao A
;
Shiraishi Kouya
;
Yu Kai
收藏
  |  
浏览/下载:102/0
  |  
提交时间:2020/01/03
Lung adenocarcinoma
Lung cancer
Mendelian randomization
Pathway analysis
Tuberculosis
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
期刊论文
2019, 卷号: 14, 期号: 5, 页码: 867-875
作者:
Wu, Yi-Long
;
Lu, Shun
;
Cheng, Ying
;
Zhou, Caicun
;
Wang, Jie
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2020/01/03
Chinese population
Nivolumab
NSCLC
Phase III clinical study
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
期刊论文
2019, 卷号: 16, 期号: 1, 页码: 189-204
作者:
Zhang Xuchao
;
Liang Zhiyong
;
Wang Shengyue
;
Lu Shun
;
Song Yong
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2020/01/03
Next-generation sequencing technology
cancer
consensus
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression
期刊论文
2019, 卷号: 145, 期号: 6, 页码: 1569-1579
作者:
Schuler, Martin
;
Tan, Eng-Huat
;
O'Byrne, Kenneth
;
Zhang, Li
;
Boyer, Michael
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2020/01/03
Afatinib
EGFR
NSCLC
Dose adjustment
Time-to-treatment failure
Expression profiling analysis of long noncoding RNAs in a mouse model of ventilator-induced lung injury indicating potential roles in inflammation
期刊论文
2019, 卷号: 120, 期号: 7, 页码: 11660-11679
作者:
Zhang, Nan-Nan
;
Zhang, Yi
;
Wang, Lu
;
Xia, Jin-Gen
;
Liang, Shun-Tao
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2020/01/03
inflammation
long noncoding RNA
RNA sequencing
ventilator-induced lung injury
New crystal forms and amorphous phase of sophoricoside: X-ray structures and characterization
期刊论文
2019, 卷号: 6, 期号: 1, 页码: 181905
作者:
Xing, Cheng
;
Zhang, Guo Shun
;
Gong, Ning Bo
;
Du, Guan Hua
;
Lu, Yang
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
sophoricoside
solvatomorphism
crystal structure
amorphous
solubility
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel
期刊论文
2018, 卷号: 7, 期号: 3, 页码: 428-436
作者:
Wu, Yi-Long
;
Wang, Chang-Li
;
Liao, Mei-Lin
;
Guan, Zhong-Zhen
;
Gao, Chen-Yan
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
Lung cancer
immunotherapy
consensus
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer
期刊论文
2018, 卷号: 13, 期号: 10, 页码: 1539-1548
作者:
Wu, Yi-Long
;
Lu, Shun
;
Lu, You
;
Zhou, Jianying
;
Shi, Yuan-kai
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/03
ALK-positive advanced non-small cell lung cancer
crizotinib
chemotherapy
phase III
©版权所有 ©2017 CSpace - Powered by
CSpace